PharVision Advisers’s Omnicom Group OMC Stock Holding History

PharVision Advisers’s Portfolio OMC Stock Details OMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,232	Closed	-$427K	–	914
2025 Q3	$427K	Buy	+5,232	New	+$395K	0.24%	56

Other funds holding OMC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PharVision Advisers's OMC Position: Q4 2025 in Review

PharVision Advisers sold out of Omnicom Group (OMC) in Q4 2025, closing a stake of 5,232 shares — an estimated $427K sold.

PharVision Advisers first reported a position in OMC in Q3 2025 and held it in 1 quarter. The position peaked at $427K in Q3 2025. 1,141 funds tracked by Wall St. Rank hold OMC as of Q4 2025.

PharVision Advisers reported no remaining Omnicom Group position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 5,232 Omnicom Group shares in Q4 2025, an estimated $427K.
PharVision Advisers first reported a position in Omnicom Group in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Omnicom Group position peaked at $427K in Q3 2025.
1,141 funds tracked by Wall St. Rank held Omnicom Group as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.